Blaming Vitamin C Price Hike On SARS Absurd, Jury Hears

Law360, New York (March 11, 2013, 7:10 PM EDT) -- A report commissioned by Chinese vitamin C manufacturers attributing sharp price increases to fears over SARS and avian flu outbreak — as opposed to industry collusion — is "nonsensical" and riddled with mathematical errors, a Stanford University economics professor testified Monday in a multidistrict litigation before a New York federal jury.

B. Douglas Bernheim criticized the report, which determines Chinese manufacturers should at most be on the hook for $2.2 million in damages for alleged price-fixing, substantially less than the $54.1 million U.S. companies are seeking...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.